Stempoint Capital »

Celcuity shares owned by Stempoint Capital

Quarter-by-quarter ownership of Celcuity (CELC) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Celcuity

Tip: Access up to 7 years of quarterly data

All positions including Celcuity held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celcuity by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.8M 137k 49.40

More positions owned by Stempoint Capital

Roivant Sciences SHS (ROIV)
Uniqure Nv SHS (QURE)
Immunovant (IMVT)
Scholar Rock Hldg Corp (SRRK)
Denali Therapeutics (DNLI)
Syndax Pharmaceuticals (SNDX)
Biohaven (BHVN)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Wave Life Sciences SHS (WVE)
Cidara Therapeutics Com New (CDTX)
Abivax Sa Sponsored Ads (ABVX)
Ideaya Biosciences (IDYA)
Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Surrozen Com New (SRZN)

View all positions for Stempoint Capital

Top funds holding Celcuity

Baker Bros. Advisors
Perceptive Advisors
BlackRock
NEA Management Company
Vanguard Group
Soleus Capital Management
Tang Capital Management
Eventide Asset Management
UBS Group
Sio Capital Management
Morgan Stanley
Apis Capital Advisors
Geode Capital Management
Deerfield Management Company
State Street Corporation

View all funds holding Celcuity